Thursday, April 25, 2019

PDA urges GPhC to redraft its pharmacy training consultation

The Pharmacy Defence Association (PDA) has expressed concerns about the General Pharmaceutical Council’s (GPhC) proposals suggested in the consultation on initial education and training. PDA,...

Novartis’ ribociclib with fulvestrant not cost effective: NICE

National Institute of Health and Care Excellence (NICE) on Wednesday published draft guidance for public consultation which does not recommend Novartis’s ribociclib (Kisqali) with...

Alert issued for unexpired batches of Chloramphenicol 0.5 % antibiotic eye drops

The Medicines and Healthcare Products Regulatory Agency (MHRA) on Tuesday issued a class 4 alert for 18 batches of Chloramphenicol 0.5 per cent W/V...
pharmacies

Negotiations begin on Community Pharmacy Contractual Framework 2019/20

The Department of Health and Social Care, NHS England and the Pharmaceutical Service Negotiating Committee have begun discussions for the Community Pharmacy Contractual Framework...

NICE gives thumbs down to metered dose inhalers

The National Institute for Health and Care Excellence (NICE) urges asthma patients to opt for a greener option while choosing their inhalers. In a new...

Drug recall for Nutriflex Omega Special 2500ml

B. Braun Medical Ltd has issued a recall of three batches of Nutriflex Omega Special 2500ml. The Medicines and Healthcare products Regulatory Agency (MHRA) said...

MHRA issues class 4 drug alert for Zoledronic acid 5 mg solution for infusion

The Medicines and Healthcare Products Regulatory Agency (MHRA) on Thursday issued a class 4 alert for Zoledronic acid 5mg solution for infusion, from Sun...

Health secretary, pharma bodies welcome new pharmacy minister

Health Secretary, Matt Hancock, and various pharmacy bodies welcomed the appointment of Seema Kennedy as the new Parliamentary Under Secretary of State for Public...

Calliditas names Schnee, Parks as board members

Calliditas Therapeutics has nominated Elmar Schnee and Diane Parks as its new board members. They are expected to be elected at the company’s annual...

NICE approves nivolumab with ipilimumab on CDF

The National Institute for Health and Care Excellence (NICE) has recommended nivolumab with ipilimumab to be made available on the Cancer Drugs Fund (CDF). The...